Match!
Acta Diabetologica
IF
3.00
Papers
3591
Papers 3625
1 page of 363 pages (3,625 results)
Newest
Published on May 15, 2019in Acta Diabetologica3.00
Irit Hochberg4
Estimated H-index: 4
(Rambam Health Care Campus),
Deeb Daoud2
Estimated H-index: 2
(Rambam Health Care Campus)
+ 1 AuthorsElad Yom-Tov1
Estimated H-index: 1
(Microsoft)
Aims Diabetes is often diagnosed late. This study aimed to assess the possibility for earlier detection of diabetes from search data, using predictive models trained on large-scale data.
Published on May 8, 2019in Acta Diabetologica3.00
Aims A meta-analysis was performed to evaluate the prognostic impact of diabetes on the clinical outcome for patients with pancreatic cancer following the adjuvant chemotherapy.
Published on May 10, 2019in Acta Diabetologica3.00
Xaynaly Souvannavong-Vilivong , Chantacha Sitticharoon4
Estimated H-index: 4
+ 5 AuthorsTripop Lertbunnaphong3
Estimated H-index: 3
Aims Adiponectin, visfatin, and omentin have been shown to be associated with insulin sensitivity and might have a role in the pathophysiology of gestational diabetes mellitus (GDM). This study aimed to (1) compare adiponectin, visfatin, and omentin mRNA expressions in placenta and their serum levels between normal pregnancy (NP) and GDM class A1 (GDMA1) pregnancy and (2) determine correlations between placental gene expressions as well as serum levels with maternal and neonatal clinical paramet...
Published on Apr 26, 2019in Acta Diabetologica3.00
Daniel Espes11
Estimated H-index: 11
,
Elin Manell2
Estimated H-index: 2
+ 5 AuthorsOlof Eriksson (Science for Life Laboratory)
Aims Perfusion of the pancreas and the islets of Langerhans is sensitive to physiological stimuli and is dysregulated in metabolic disease. Pancreatic perfusion can be assessed by both positron emission tomography (PET) and magnetic resonance imaging (MRI), but the methods have not been directly compared or benchmarked against the gold-standard microsphere technique.
Published on May 14, 2019in Acta Diabetologica3.00
Matias Iglicki5
Estimated H-index: 5
,
Dinah Zur6
Estimated H-index: 6
+ 11 AuthorsMatus Rehak14
Estimated H-index: 14
Aim Main failure of diabetic tractional retinal detachment (TRD) surgery is the development of proliferative vitreoretinopathy (PVR), causing higher re-detachment rates. We investigated whether the use of dexamethasone (DEX) implant at the end of pars plana vitrectomy (PPV) with silicone oil tamponade might have an impact on these outcomes.
Published on May 22, 2019in Acta Diabetologica3.00
B. Bouillet11
Estimated H-index: 11
,
Thomas Gautier21
Estimated H-index: 21
(French Institute of Health and Medical Research)
+ 4 AuthorsB. Vergès38
Estimated H-index: 38
Published on Apr 15, 2019in Acta Diabetologica3.00
María Cristina Gil-Díaz (UR: University of Rochester), Jennifer Raynor (URMC: University of Rochester Medical Center)+ 2 AuthorsDavid R. Weber11
Estimated H-index: 11
(UR: University of Rochester)
Aims The skeletal complications of type 1 diabetes (T1D) include low bone density, poor bone quality and fractures. Greater calcium intake, vitamin D intake, and physical activity are commonly recommended to improve bone health in patients with T1D. However, it is not clear whether these factors are affected by T1D or improve clinical outcomes.
Published on 2019in Acta Diabetologica3.00
Linman Li1
Estimated H-index: 1
(CQMU: Chongqing Medical University),
Wenyi You1
Estimated H-index: 1
,
Wei Ren7
Estimated H-index: 7
(CQMU: Chongqing Medical University)
Published on 2019in Acta Diabetologica3.00
Fulvio Pomero15
Estimated H-index: 15
,
Francesco Dentali40
Estimated H-index: 40
+ 4 AuthorsDaniela Mastroiacovo5
Estimated H-index: 5
Published on Sep 21, 2019in Acta Diabetologica3.00
Stela Vujosevic19
Estimated H-index: 19
,
Caterina Toma + 7 AuthorsStefano De Cillà3
Estimated H-index: 3
Purpose To assess and compare early changes in neuroinflammatory and vascular parameters in diabetic macular edema (DME) with subfoveal neuroretinal detachment (SND) after treatment with intravitreal dexamethasone (DEX-I) and ranibizumab (IVR).
12345678910